Cargando…
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models
BACKGROUND: Despite antiretroviral treatment efficacy, it does not lead to the complete eradication of HIV infection. Consequently, reactivation of the virus from latently infected cell reservoirs is a major challenge toward cure efforts. Two strategies targeting viral latency are currently under in...
Autores principales: | da Costa, Lendel Correia, Bomfim, Larissa Maciel, Dittz, Uilla Victoria Torres, Velozo, Camila de Almeida, da Cunha, Rodrigo Delvecchio, Tanuri, Amilcar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215058/ https://www.ncbi.nlm.nih.gov/pubmed/35733180 http://dx.doi.org/10.1186/s12977-022-00600-9 |
Ejemplares similares
-
Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
por: Zheng, Hanxiong, et al.
Publicado: (2021) -
Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability
por: Zhao, Jun, et al.
Publicado: (2021) -
Using the dCas9-KRAB system to repress gene expression in hiPSC-derived NGN2 neurons
por: Li, Aiqun, et al.
Publicado: (2021) -
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019) -
CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells
por: Roy Choudhury, Samrat, et al.
Publicado: (2023)